ANI Pharmaceuticals, Inc.
ANIP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,067,899 | $992,575 | $654,140 | $580,424 |
| - Cash | $144,861 | $221,121 | $48,228 | $100,300 |
| + Debt | $624,092 | $285,669 | $286,519 | $287,370 |
| Enterprise Value | $1,547,130 | $1,057,123 | $892,431 | $767,494 |
| Revenue | $614,376 | $486,816 | $316,385 | $216,136 |
| % Growth | 26.2% | 53.9% | 46.4% | – |
| Gross Profit | $364,166 | $305,303 | $177,600 | $115,526 |
| % Margin | 59.3% | 62.7% | 56.1% | 53.5% |
| EBITDA | $63,121 | $106,603 | $25,040 | $3,116 |
| % Margin | 10.3% | 21.9% | 7.9% | 1.4% |
| Net Income | -$18,522 | $18,779 | -$47,896 | -$42,603 |
| % Margin | -3% | 3.9% | -15.1% | -19.7% |
| EPS Diluted | -1.04 | 0.94 | -3.05 | -3.4 |
| % Growth | -210.6% | 130.8% | 10.3% | – |
| Operating Cash Flow | $64,017 | $118,959 | -$31,203 | $3,322 |
| Capital Expenditures | -$16,953 | -$18,511 | -$16,455 | -$23,638 |
| Free Cash Flow | $47,064 | $100,448 | -$47,658 | -$20,316 |